IMMVF Projected Dividend Yield
Shs/Immunovia AB ( OTCBB : IMMVF )Immunovia is a diagnostics company with its technology platform IMMray™ for developing and commercializing blood tests for the diagnosis of cancer and autoimmune diseases. Co. is in the process of launching its product IMMray™PanCan-d, a test that detects pancreatic cancer with high accuracy at an early stage thereby meeting a medical need. Co.'s goal is to be the first company to launch a blood test for early detection of pancreatic cancer. Furthermore, the aim is to establish it as the standard test for specialists in pancreatic cancer and diabetes worldwide for detecting pancreatic cancer in high-risk groups at an earlier stage than is possible today. 20 YEAR PERFORMANCE RESULTS |
IMMVF Dividend History Detail IMMVF Dividend News IMMVF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |